Gobel David 4

What Happened David Gobel, a director of VivoSim Labs, received a grant of 15,000 restricted stock units (RSUs) on January 27, 2026. The grant is reported as an acquisition (transaction code A) at an acquisition price of $0.00 (total reported cash value $0). These are RSUs — not currently tradable shares — and will convert to shares if and when they vest.

Key Details

• Transaction date: 2026-01-27 (Form 4 filed 2026-01-29; filing appears timely under the 2-business-day rule).
• Transaction type/code: Grant/Award (A).
• Amount: 15,000 RSUs; reported acquisition price $0.00.
• Shares owned after transaction: not specified in the filing.
• Footnote: RSUs vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders, subject to acceleration upon a change of control (Footnote F1).
• Exhibit noted: Exhibit 24 — Power of Attorney.

Context RSUs are a form of equity compensation that convert into common shares only after vesting; they are not an immediate market buy or sell. Grants like this reflect compensation or retention measures rather than an immediate trading signal. The vesting schedule and change-of-control acceleration are the key conditions determining when these units become actual shares.